Sodertalje, Sweden

Can Slivo

USPTO Granted Patents = 5 


Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Södertälje, SE (2011)
  • Sodertalje, SE (2010 - 2015)

Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Revolutionizing Alzheimer's Diagnosis: The Innovations of Can Slivo

Introduction: Can Slivo is an accomplished inventor based in Södertälje, Sweden, known for his significant contributions to the field of pharmaceuticals. He holds five patents, showcasing his dedication to advancing medical science, particularly in the diagnosis and treatment of Alzheimer's disease.

Latest Patents: Slivo's latest patents focus on heteroaryl substituted benzothiazoles. These novel derivatives are designed to serve both as therapeutic agents and for imaging amyloid deposits in living patients. His work involves the use of these compounds to enable antemortem diagnoses of Alzheimer's disease, as well as assessing the clinical efficacy of various therapeutic agents aimed at treating the condition. The innovative structural formula behind these compounds exemplifies the potential impact of Slivo's inventions in the realm of medical diagnostics.

Career Highlights: Throughout his career, Can Slivo has made notable strides in the pharmaceutical industry. He has contributed his expertise to renowned companies like AstraZeneca AB and Navidea Biopharmaceuticals, Inc., where he has played a pivotal role in developing innovative healthcare solutions. His focus on research and development in the pharmaceutical domain has set a benchmark for excellence and creativity.

Collaborations: Collaboration has been a key element in Slivo's journey as an inventor. He has worked alongside distinguished colleagues, including Gunnar Nordvall and Jonas Malmström. Together, they have shared insights and expertise that have enriched their collective contributions to the field, strengthening the drive for innovative solutions in medicine.

Conclusion: Can Slivo stands out as a prominent figure in innovation, particularly in the field of Alzheimer's disease diagnostics. His patents, highlighting heteroaryl substituted benzothiazoles, represent significant advancements in therapeutic uses and imaging techniques. With a strong foundation in pharmaceutical research and collaborative efforts, Slivo continues to push the boundaries of what is possible in medical innovation, paving the way for a brighter future in Alzheimer's treatment and diagnosis.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…